comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-12 08:29:39 - browse：6285

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Study: Pain burden is higher in Black NFL players than white ones

focus

WSS

Sanders adds drug shortage policies to pandemic preparedness bill

Medicare has a new plan to address drug shortages

Why 40% Americans with Parkinson’s don’t see a neurologist

Leqembi, other new Alzheimer’s drugs require better biomarkers

Startup Neumora takes a novel depression drug to Phase 3

Cosmetics set for new safety regulation. Why the industry is on board

explore

comprehensive

The need-to-know this morning

Novavax’s money is going in the wrong direction

entertainment

Continuity nursing helped my family in our darkest PICU moments

HCA discloses massive data breach affecting 11 million patients

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden launches a new push to limit health care costs

Medicare proposal to cover medical devices draws a mixed reaction

As digital health tech proliferates, a new institute aims to cut through hype

Virginia high school admissions case could be legal follow

Group opposing PBM reform sets lobbying record

Medicare details structure of new drug price negotiation program

How Medicaid coverage policies for immigrants impact new moms

leisure time

Why 40% Americans with Parkinson’s don’t see a neurologist

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

Charles Manson follower Leslie Van Houten released from prison after 53 years

In early work, researchers turn to CRISPR to treat Alzheimer's

Iowa House, Senate pass 6

Iowa House, Senate pass 6

Wikipedia

focus

leisure time

explore